))
Ad Promo Review in Pharma - How Far is Too Far?
Manage episode 450491358 series 3506216
Konten disediakan oleh Darshan Kulkarni. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Darshan Kulkarni atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Katie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.
Key topics include:
- What is Ad Promo?
- Chevron decision's influence on FDA/FTC
- Should administrative agencies cite letters?
- Can the FDA establish rules after someone challenges them?
- Uncertainty of Compliance White Space
- Is regulatory medical advice now just seen as a risk?
148 episode
Bagikan
